Shares of NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of C$5.02 and traded as low as C$4.53. NorthWest Health Prop Real Est Inv Trust shares last traded at C$4.61, with a volume of 609,166 shares.
Analyst Upgrades and Downgrades
Separately, BMO Capital Markets decreased their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.25 in a research note on Tuesday, November 19th.
Read Our Latest Research Report on NorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust Price Performance
The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42. The stock has a market cap of C$1.14 billion, a P/E ratio of -2.91, a P/E/G ratio of 0.74 and a beta of 1.05. The firm has a 50 day moving average price of C$4.82 and a 200 day moving average price of C$5.01.
About NorthWest Health Prop Real Est Inv Trust
(
Get Free Report)
NorthWest Healthcare Properties Real Estate Investment Trust TSX: NWH.UN (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
Further Reading
Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.
While NorthWest Health Prop Real Est Inv Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
